v3.22.1
Consolidated Statements of Operation - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Revenues $ 15,641 $ 6,137 $ 2,318
Cost of revenues 2,005 3,002 1,879
Gross Profit 13,636 3,135 439
Operating expenses:      
Research and development, net 7,631 4,065 4,414
General, administrative and marketing 5,940 4,669 3,656
Total operating income (loss) 65 (5,599) (7,631)
Financial income (expenses), net 172 (175) (3,533)
Net income (loss) $ 237 $ (5,774) $ (11,164)
Basic net income (loss) per ordinary share (in Dollars per share) $ 0.02 $ (0.84) $ (2.23)
Diluted net income (loss) per ordinary share (in Dollars per share) $ 0.02 $ (0.84) $ (2.23)
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares) 9,968,972 6,886,955 4,986,381
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares) 11,966,788 6,886,955 4,986,381

Source